Development of an improved time-resolved fluoroimmunoassay for simultaneous quantification of C-peptide and insulin in human serum

Clinical Biochemistry

Volumn 47, Issue 6, 2014, Pages 439-444

  Liu, Tian Cai ^a   Chen, Mei Jun ^a   Ren, Zhi Qi ^a   Hou, Jing Yuan ^a   Lin, Guan Feng ^a   Wu, Ying Song ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

C peptide; Insulin; Magnetic particles; Simultaneous quantification; Time resolved fluoroimmunoassay

Indexed keywords

C PEPTIDE; CHELATE; EUROPIUM; INSULIN; SAMARIUM; ANTIBODY; GLUCAGON;

ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COATED PARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FLUOROIMMUNOASSAY; HUMAN; IMMUNOASSAY ANALYZER; IMMUNOMAGNETIC SEPARATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLID; TIME RESOLVED FLUOROIMMUNOASSAY; VALIDATION PROCESS; BLOOD; CALIBRATION; DIABETES MELLITUS; MAGNETISM; METABOLISM; PROCEDURES; REPRODUCIBILITY; TIME;

ANTIBODIES; C-PEPTIDE; CALIBRATION; DIABETES MELLITUS; FLUOROIMMUNOASSAY; GLUCAGON; HUMANS; INSULIN; LIMIT OF DETECTION; MAGNETIC PHENOMENA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84897459381     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.01.016     Document Type: Article

References (38)

1. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., et al. National, regional, and global trends in fasting serum glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7million participants. Lancet 2011, 378:31-40.
2. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
3. Rubenstein A.H., Block M.B., Starr J., Melani F., Steiner D.F. Proinsulin and C-peptide in blood. Diabetes 1972, 21:661-672.
4. Forst T., Kunt T., Pohlmann T., Goitom K., Engelbach M., Beyer J., et al. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest 1998, 101:2036-2041.
5. Cryer P.E., Axelrod L., Grossman A.B., Heller S.R., Montori V.M., Seaquist E.R., et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009, 94:709-728.
6. Johansson B.L., Borg K., Fernqvist-Forbes E., Kernell A., Odergren T., Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 2000, 17:181-189.
7. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev 2005, 26:19-39.
8. Mallone R., Roep B.O. Clin Immunol 2013, 10.1016/j.clim.2013.02.009.
9. Mork T.A., Killeen C.T., Patel N.K., Dohnal J.M., Karydes H.C., Leikin J.B. Massive insulin overdose managed by monitoring daily insulin levels. Am J Ther 2011, 18:e162-e166.
10. Brundin T. Splanchnic and extrasplanchnic extraction of insulin following oral and intravenous glucose loads. Clin Sci (Lond) 1999, 97:429-436.
11. Lopez X., Cypess A., Manning R., O'Shea S., Kulkarni R.N., Goldfine A.B. Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids. J Clin Endocrinol Metab 2011, 96:3811-3821.
12. Brandenburg D. History and diagnostic significance of C-peptide. Exp Diabetes Res 2008, 2008. 10.1155/2008/576862.
13. Valensise H., Larciprete G., Vasapollo B., Novelli G.P., Menghini S., di Pierro G. C-peptide and insulin levels at 24-30weeks' gestation: an increased risk of adverse pregnancy outcomes?. Eur J Obstet Gynecol Reprod Biol 2002, 103:130-135.
14. Wu T., Willett W.C., Hankinson S.E., Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to serum C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 2005, 28:1390-1396.
15. Coelho C., Druce M.R., Grossman A.B. Diagnosis of insulinoma in a patient with hypoglycemia without obvious hyperinsulinemia. Nat Rev Endocrinol 2009, 5:628-631.
16. Vezzosi D., Bennet A., Fauvel J., Caron P. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol 2007, 157:75-83.
17. Ludvigsson J., Carlsson A., Forsander G., Ivarsson S., Kockum I., Lernmark A., et al. C-peptide in the classification of diabetes in children and adolescents. Pediatr Diabetes 2012, 13:45-50.
18. Guo Z.Y., Hao T.T., Du SP, Chen BB, Wang ZB, Li X, et al. Multiplex electrochemiluminescence immunoassay of two tumor markers using multicolor quantum dots as labels and graphene as conducting bridge. Biosens Bioelectron 2013, 44:101-107.
19. Zhang L., Gao L., Zhou B., Zhu L., Zhang Y., Huang B. Simultaneous detection of deoxynivalenol and zearalenone by dual-label time-resolved fluorescence immunoassay. J Sci Food Agric 2011, 91:193-197.
20. Zucchelli G.C., Clerico A., Pilo A., Masini S., Zoppi F., Bovati M.L., et al. Evaluation and comparison of radioimmunoassay methods using monoclonal or polyclonal antibodies for the assay of cyclosporine in blood samples. Int J Tissue React 1989, 11:315-320.
21. Christenson R.H., Duh S.H., Wu A.H., Smith A., Abel G., deFilippi C.R., et al. Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure. Clin Biochem 2010, 43:683-690.
22. Fukada H., Hiramatsu N., Kitamura M., Chiba H., Hara A. Chemiluminescent immunoassay (CLIA) for salmon growth hormone (GH). J Biolumin Chemilumin 1997, 12:271-275.
23. Stéphanie C.G., JérÔme S. Lanthanide-based conjugates as polyvalent probes for biological labeling. Eur J Inorg Chem 2008, 2008:2856-2862.
24. Xu Y.Y., Hemmilä I.A. Analytical application of the co-fluorescence effect in detection of europium, terbium, samarium and dysprosium with time-resolved fluorimetry. Talanta 1992, 39:759-763.
25. Hemmilä I. Lanthanides as probes for time-resolved fluorometric immunoassays. Scand J Clin Lab Invest 1988, 48:389-399.
26. Hagan A.K., Zuchner T. Lanthanide-based time-resolved luminescence immunoassays. Anal Bioanal Chem 2011, 400:2847-2864.
27. Regulacio M.D., Pablico M.H., Vasquez J.A., Myers P.N., Gentry S., Prushan M., et al. Luminescence of LnIII dithiocarbamate complexes (Ln=La, Pr, Sm, Eu, Gd, Tb, Dy). Inorg Chem 2008, 47:1512-1523.
28. 3+ phosphors. Phys Chem Chem Phys 2012, 14:296-307.
29. Ma Q., Li L.Q., He A., Lin GF, Zou LP, Wu YS, et al. Development of the dual-labeling time-resolved fluoroimmunoassay for detection of C-peptide and insulin and its initially application. Prog Biochem Biophys 2011, 38:670-676. [in Chinese].
30. Tang W., Su Y., Li Q., Gao S., Shang J.K. Superparamagnetic magnesium ferrite nanoadsorbent for effective arsenic (III, V) removal and easy magnetic separation. Water Res 2013, 47:3624-3634.
31. Gomez D.E., Hartzler J.L., Corbitt R.H., Nason A.M., Thorgeirsson U.P. Immunomagnetic separation as a final purification step of liver endothelial cells. In Vitro Cell Dev Biol Anim 1993, 29A:451-455.
32. Stewart L.D., McNair J., McCallan L., Gordon A., Grant I.R. Improved detection of Mycobacterium bovis infection in bovine lymph node tissue using immunomagnetic separation (IMS)-based methods. PLoS One 2013, 8:e58374. 10.1371/journal.pone.0058374.
33. Hou J.Y., Liu T.C., Ren Z.Q., Chen M.J., Lin G.F., Wu Y.S. Magnetic particle-based time-resolved fluoroimmunoassay for the simultaneous determination of α-fetoprotein and the free β-subunit of human chorionic gonadotropin. Analyst 2013, 138:3697-3704.
34. Hou J.Y., Liu T.C., Li Z.X., Zou L.P., Li M., Wu Y.S. Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum. Anal Chim Acta 2012, 734:93-98.
35. Lin G.F., Liu T.C., Hou J.Y., Zou L.P., Wu Y.S. Development of a dual-label time-resolved fluoroimmunoassay for the detection of α-fetoprotein and hepatitis B virus surface antigen. Luminescence 2012, 10.1002/bio.2396.
36. Findlay J.W., Smith W.C., Lee J.W., Nordblom G.D., Das I., DeSilva B.S., et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal 2000, 21:1249-1273.
37. Even M.S., Sandusky C.B., Barnard N.D., Mistry J., Sinha M.K. Development of a novel ELISA for human insulin using monoclonal antibodies produced in serum-free cell culture medium. Clin Biochem 2007, 40:98-103.
38. Ryder K.W., Glick M.R. Erroneous laboratory results from hemolyzed, icteric, and lipemic specimens. Clin Chem 1993, 39:175-176.